Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2014 by University of Regensburg
Sponsor:
Collaborator:
Technische Universität München
Information provided by (Responsible Party):
Karl-Michael Schebesch, University of Regensburg
ClinicalTrials.gov Identifier:
NCT01292278
First received: February 8, 2011
Last updated: December 4, 2014
Last verified: December 2014

February 8, 2011
December 4, 2014
January 2006
August 2015   (final data collection date for primary outcome measure)
Glasgow Outcome Scale [ Time Frame: 2011-2016 ] [ Designated as safety issue: No ]
Not Provided
Complete list of historical versions of study NCT01292278 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients
The Possible Role of Neuropeptide Y After Spontaneous Subarachnoid Hemorrhage

Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.

Evaluation of Neuropeptides in CSF and serum in SAH patients

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

cerebrospinal fluid / serum

Probability Sample

consecutive pts. with subarachnoid hemorrhage

Subarachnoid Hemorrhage
Not Provided
  • aSAH
    consecutive patients with spontaneous or aneurysmal subarachnoid hemorrhage
  • control group
    no neurological disease but spinal anesthesia
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
90
December 2016
August 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • spontaneous or aneurysmal subarachnoid hemorrhage

Exclusion Criteria:

  • age younger than 18 years or older than 70 years
  • inflammatory disease
  • history of former SAH
  • no ventricular drainage
Both
18 Years to 70 Years
Yes
Germany
 
NCT01292278
CSF 06/179
Yes
Karl-Michael Schebesch, University of Regensburg
University of Regensburg
Technische Universität München
Not Provided
University of Regensburg
December 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP